255 results match your criteria: "From Harvard Medical School[Affiliation]"
Harv Rev Psychiatry
October 2021
From Harvard Medical School; Division of Digital Psychiatry, Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA (Drs. Benoit, Keshavan, and Torous); Cardiac Psychiatry Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, MA (Dr. Onyeaka).
Background: Digital phenotyping is the use of data from smartphones and wearables collected in situ for capturing a digital expression of human behaviors. Digital phenotyping techniques can be used to analyze both passively (e.g.
View Article and Find Full Text PDFN Engl J Med
September 2020
From Harvard Medical School and the Division of Global Health Equity and Department of Medicine, Brigham and Women's Hospital - both in Boston (C.N.C.); the Department of Emergency Medicine, University of California, Los Angeles, Los Angeles (H.J.); the Refugee Health Alliance, La Jolla, CA (H.J.); and the Refugee Health Alliance, Tijuana, Mexico (H.J.).
Radiology
December 2020
From Harvard Medical School, Harvard University, Boston, Mass (N.P.J., N.J.R.); Departments of Radiology (A.S., M.D.L., M.L., F.D., D.P.M., B.P.L., A.K.N., E.J.F.), Internal Medicine (E.P.H., C.M.D., J.R.B.), Infectious Diseases (E.P.H., C.M.D.), and Center for Equity and Inclusion (J.R.B.), Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114.
Background Disease severity on chest radiographs has been associated with higher risk of disease progression and adverse outcomes from coronavirus disease 2019 (COVID-19). Few studies have evaluated COVID-19-related racial and/or ethnic disparities in radiology. Purpose To evaluate whether non-White minority patients hospitalized with confirmed COVID-19 infection presented with increased severity on admission chest radiographs compared with White or non-Hispanic patients.
View Article and Find Full Text PDFNeurology
August 2020
From Harvard Medical School (E.A., S.S.M., S.S.C., M.T.B., M.B.W.); Department of Neurology (E.A., S.S.C., M.T.B., M.B.W.), Massachusetts General Hospital, Boston; Department of Neurology (E.A.), University of California, San Francisco; and Computer Science and Artificial Intelligence Laboratory (E.A., S.P.) and Department of Electrical Engineering and Computer Science (M.M.G., W.-H.W.), Massachusetts Institute of Technology, Cambridge.
Objective: To determine cost-effectiveness parameters for EEG monitoring in cardiac arrest prognostication.
Methods: We conducted a cost-effectiveness analysis to estimate the cost per quality-adjusted life-year (QALY) gained by adding continuous EEG monitoring to standard cardiac arrest prognostication using the American Academy of Neurology Practice Parameter (AANPP) decision algorithm: neurologic examination, somatosensory evoked potentials, and neuron-specific enolase. We explored lifetime cost-effectiveness in a closed system that incorporates revenue back into the medical system (return) from payers who survive a cardiac arrest with good outcome and contribute to the health system during the remaining years of life.
J Law Med Ethics
June 2020
Christine M. Baugh, Ph.D., M.P.H., is an Assistant Professor of Medicine in the Division of General Internal Medicine at the University of Colorado and Core Research Faculty at the Center for Bioethics and Humanities at the University of Colorado. She received a Doctor of Philosophy (Ph.D.) in Health Policy and Bioethics from Harvard University (Cambridge, MA), a Master's Degree in Public Health (M.P.H.) concentrating in Health Law, Bioethics, and Human Rights from Boston University School of Public Health (Boston, MA) and a Bachelor of Arts (B.A.) in history and science from Harvard University (Cambridge, MA). Emily Kroshus, Sc.D., M.P.H., is a Research Assistant Professor at University of Washington in the Department of Pediatrics, based at the Seattle Children's Research Institute in the Center for Child Health, Behavior and Development. She received her Doctor of Science (Sc.D.) from Harvard University's School of Public Health in the Department of Social and Behavioral Sciences, where she also received a certificate in Health Communication (Boston, MA). She has a master's degree in public health (M.P.H.) from Johns Hopkins University's Bloomberg School of Public Health (Baltimore, MD), and a bachelor of arts (B.A.) degree in economics from Princeton University (Princeton, NJ). William P. Meehan III, M.D., is an Associate Professor of Pediatrics and Orthopedics at Harvard Medical School, Director of the Micheli Center for Sports Injury Prevention, and Director of Research for the Brain Injury Center at Boston Children's Hospital. He received his medical doctorate (M.D.) from Harvard Medical School (Boston, MA) and his bachelor of arts (B.A.) from Boston College (Boston, MA). Eric G. Campbell, Ph.D., is a Professor of Medicine in the Division of General Internal Medicine at the University of Colorado and Director of Research at the Center for Bioethics and Humanities at the University of Colorado. He received his Doctor of Philosophy (Ph.D.) in Higher Educational Policy and Administration from the University of Minnesota (Minneapolis, MN), his Masters of Arts (M.A.) in Education from the University of Minnesota (Minneapolis, MN), and his Bachelor of Arts (B.A.) in Psychology from the University of Minnesota (Minneapolis, MN).
Sports medicine clinicians face conflicts of interest in providing medical care to athletes. Using a survey of college football players, this study evaluates whether athletes are aware of these conflicts of interest, whether these conflicts affect athlete trust in their health care providers, or whether conflicts or athletes' trust in stakeholders are associated with athletes' injury reporting behaviors.
View Article and Find Full Text PDFJ Law Med Ethics
June 2020
Stefan G. Kertesz, M.D., M.Sc., is a professor at the Department of Medicine, UAB School of Medicine and research investigator at the Birmingham VA Medical Center. He is a board-certified internal medicine (American Board of Internal Medicine) and addiction medicine physician (American Board of Addiction Medicine). His research career began in 2000 and he has been funded by both the National Institute on Drug Abuse and the Health Services Research & Development Branch of the Department of Veterans Affairs. He received his MD from Harvard Medical School in Boston, MA and his MSc from Boston University School of Public Health in Boston, MA. Ajay Manhapra, M.D., is Lecturer at Yale School of Medicine in the Department of Psychiatry, Assistant Professor, at the Eastern Virginia Medical School in the Department of Physical Medicine and Rehabilitation and Psychiatry, and Research Scientist at the VA New England Mental Illness Research, Education and Clinical Center. Dr. Manhapra is a board-certified Internist and Addiction Medicine physician with educational, clinical and research focus on pain and addiction. He runs a unique clinic for recovering patients with severe disabling chronic pain and medication or substance dependence at Hampton VA Medical Center, where he is developing an interdisciplinary integrative model for treatment of pain and addiction. Dr. Manhapra received his medical degree from Government Medical College, Thrissur, Kerala, India, and completed his Addiction Medicine fellowship at Yale School of Medicine. Adam J. Gordon, M.D., M.P.H., is Professor of Medicine and Psychiatry at the University of Utah School of Medicine, Director of the Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA), and Chief of Addiction Medicine at VA Salt Lake City Health Care System and. He is a board-certified internal medicine (American Board of Internal Medicine) and addiction medicine physician (American Board of Preventive Medicine) with a 20-year track record of conducting research on the quality, equity, and efficiency of health care for vulnerable populations (e.g., persons with opioid use disorders, persons who are homeless, persons with hazardous alcohol use and other addiction disorders). He received his MD from University of Pittsburgh School of Medicine in Pittsburgh, PA and his MPH from the University of Pittsburgh Graduate School of Public Health in Pittsburgh, PA.
This manuscript describes the institutional and clinical considerations that apply to the question of whether to mandate opioid dose reduction in patients who have received opioids long-term. It describes how a calamitous rise in addiction and overdose involving opioids has both led to a clinical recalibration by healthcare providers, and to strong incentives favoring forcible opioid reduction by policy making agencies. Neither the 2016 Guideline issued by the Centers for Disease Control and Prevention nor clinical evidence can justify or promote such policies as safe or effective.
View Article and Find Full Text PDFHarv Rev Psychiatry
October 2021
From Harvard Medical School; Departments of Psychiatry (Drs. Shah, Barsky, Mufson, and Teslyar) and Medicine (Drs. Hamilton and Rittenberg), Brigham and Women's Hospital, Boston, MA.
Harv Rev Psychiatry
October 2021
From Harvard Medical School (Ms. Mitchell and Drs. Montgomery and Suzuki); Ethics Service and Center for Nursing Excellence (Dr. Millikin), Division of Infectious Diseases (Dr. Montgomery), and Department of Psychiatry (Dr. Suzuki), Brigham and Women's Hospital, Boston, MA; Division of Cardiac Surgery, University of Toronto, Trillium Health Partners, Toronto, Canada (Dr. Singh).
Harv Rev Psychiatry
October 2021
From Harvard Medical School (Dr. Scher); McLean Hospital, Belmont, MA (Dr. Scher); Disciplines of Psychiatry (Drs. Scher and Kozlowska) and of Child and Adolescent Health (Dr. Kozlowska), University of Sydney Medical School; The Children's Hospital at Westmead, Westmead, New South Wales (Dr. Kozlowska); Brain Dynamics Centre, Westmead Institute for Medical Research, Westmead, New South Wales (Dr. Kozlowska).
Harv Rev Psychiatry
October 2021
From Harvard Medical School (Drs. Thom, Keary, Nowinski, and McDougle); Massachusetts General Hospital, Boston, MA (Drs. Thom, Keary, Nowinski, and McDougle); Lurie Center for Autism, Lexington, MA (Drs. Keary, Nowinski, and McDougle); Hillsdale College, Hillsdale, MI (Mr. Kramer).
Although autism spectrum disorder (ASD) is the prototypical psychiatric disorder of social impairment, several if not most psychiatric disorders are characterized by prominent impairments in social functioning. A challenge in clinically assessing and describing social impairment is that it has been variably defined and can be difficult to measure. In this article we consider the psychiatric differential diagnosis of social impairment within the DSM-5 framework.
View Article and Find Full Text PDFHarv Rev Psychiatry
October 2021
From Harvard Medical School; Brigham and Women's Hospital, Boston, MA (Drs. Kosman, Almeida, Salama, and Teslyar); Beth Israel Deaconess Hospital, Boston, MA (Drs. Kosman and Salzman); Massachusetts Mental Health Center, Boston, MA (Dr. Salzman).
N Engl J Med
July 2020
From Harvard Medical School (I.Z.-O., R.M.S.) and the Division of Pulmonary, Critical Care, and Sleep Medicine, Beth Israel Deaconess Medical Center (R.M.S.) - both in Boston.
Harv Rev Psychiatry
October 2021
From Harvard Medical School (Drs. Hsu, Baslet, Sanchez, Levy-Carrick, and Suzuki); Department of Psychiatry, Brigham and Women's Hospital, Boston, MA (Drs. Hsu, Baslet, Sanchez, Levy-Carrick, and Suzuki); Boston University School of Medicine (Dr. Farahmand).
N Engl J Med
May 2020
From Harvard Medical School (M.J.B., D.B.) and the Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital (D.B.) - both in Boston; and the Departments of Medical Social Sciences, Medical Education, and Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago (K.L.W.).
Harv Rev Psychiatry
June 2021
From Harvard Medical School (Ms. Roth); Department of Transplant Surgery, Johns Hopkins University (Drs. Lee and Cameron); Weill Cornell Medical College (Drs. Shen and Brown); Starzl Transplant Institute, University of Pittsburgh School of Medicine and Medical Center (Dr. DiMartini); Columbia University Medical Center, Center for Liver Disease and Transplantation (Dr. Shenoy).
Harv Rev Psychiatry
June 2021
From Harvard Medical School; Harvard South Shore Psychiatry Residency Training Program, VA Boston Healthcare System, Brockton, MA; Department of Psychiatry, Boston Children's Hospital, Boston, MA (Dr. Mari).
The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders defines internet gaming disorder without differentiating games from their respective genres, such as first-person shooter versus real-time strategy versus online gaming. Our review of the literature on massively multiplayer online role-playing games (MMORPGs) suggests that MMORPGs are different from other games because they are the most addictive, and therefore deserve to be looked at separately. MMORPGs are internet platforms for online users to interact with each other in a virtual story line.
View Article and Find Full Text PDFHarv Rev Psychiatry
June 2021
From Harvard Medical School (Drs. Hsiang Huang and Ghaemi); Cambridge Health Alliance, Cambridge, MA (Drs. Hsiang Huang and Ghaemi); University of Wisconsin School of Medicine and Public Health (Dr. Heather Huang); Department of Psychiatry, University of Vermont College of Medicine (Dr. Spottswood); Community Health Centers of Burlington, Burlington, VT (Dr. Spottswood); Tufts University (Dr. Ghaemi).
Requests for the evaluation of potential adult attention-deficit/hyperactivity disorder (ADHD) is on the rise across primary care clinics. Many health care providers, however, may feel ill equipped to diagnose and manage adults presenting with inattention and impulsivity. The diagnosis of ADHD is often complicated by medical and psychiatric conditions that can contribute to inattention symptoms.
View Article and Find Full Text PDFHarv Rev Psychiatry
June 2021
From Harvard Medical School (Dr. Alegría); Disparities Research Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts (Dr. Alegría and Ms. O'Malley).
Harv Rev Psychiatry
June 2021
From Harvard Medical School; Department of Psychiatry, Massachusetts General Hospital, Boston, MA; Department of Epidemiology, Harvard T.H. Chan School of Public Health (Dr. Okereke); Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA (Dr. Okereke).
After participating in this activity, learners should be better able to:• Identify risk factors for late-life depression• Evaluate strategies to prevent late-life depression ABSTRACT: Late-life depression (LLD) is one of the major sources of morbidity and mortality in the world. Because LLD is related to increased public health burden, excess health care costs and utilization, reduced quality of life, and increased mortality, prevention is a priority. Older adults differ from younger adults with respect to key features, such as their chronicity and lifetime burden of depression and their constellation of comorbidities and risk factors.
View Article and Find Full Text PDF